Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Specialized Pro-Resolving Lipid Mediators in Pulmonary Diseases: Molecular and Therapeutic Implications

Á. Ortega, P. Duran, B. Garrido, A. Manzano, C. Navarro, A. Silva, M. Rojas, JB. De Sanctis, D. Radzioch, D. Rivera-Porras, CS. Paredes, V. Bermúdez

. 2025 ; 30 (10) : . [pub] 20250519

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc25015712

Inflammatory lung diseases (ILDs) represent a global public health crisis characterized by escalating prevalence, significant morbidity, and substantial mortality. In response to the complex immunopathogenic mechanisms driving these conditions, novel pharmacological strategies targeting resolution pathways have emerged throughout the discovery of specialized pro-resolving lipid mediator (SPM; resolvins, maresins, and protectins) dysregulation across the ILD spectra, positioning these endogenous molecules as promising therapeutic candidates for modulating maladaptive inflammation and promoting tissue repair. Over the past decade, this paradigm has catalyzed extensive translational research into SPM-based interventions as precision therapeutics for respiratory inflammation. In asthma, they reduce mucus hypersecretion, bronchial hyperreactivity, and airway inflammation, with prenatal SPM exposure potentially lowering offspring disease risk. In COPD, SPMs attenuate amyloid A-driven inflammation, normalizing cytokine/chemokine imbalances and oxidative stress and mitigating COVID-19-associated cytokine storm, enhancing survival. This review synthesizes SPMs' pharmacotherapeutic mechanisms in ILDs and evaluates current preclinical and clinical evidence.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25015712
003      
CZ-PrNML
005      
20250731091200.0
007      
ta
008      
250708s2025 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/molecules30102212 $2 doi
035    __
$a (PubMed)40430385
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Ortega, Ángel $u Endocrine and Metabolic Diseases Research Center, School of Medicine, University of Zulia, Maracaibo 4001, Venezuela $1 https://orcid.org/0000000271804765
245    10
$a Specialized Pro-Resolving Lipid Mediators in Pulmonary Diseases: Molecular and Therapeutic Implications / $c Á. Ortega, P. Duran, B. Garrido, A. Manzano, C. Navarro, A. Silva, M. Rojas, JB. De Sanctis, D. Radzioch, D. Rivera-Porras, CS. Paredes, V. Bermúdez
520    9_
$a Inflammatory lung diseases (ILDs) represent a global public health crisis characterized by escalating prevalence, significant morbidity, and substantial mortality. In response to the complex immunopathogenic mechanisms driving these conditions, novel pharmacological strategies targeting resolution pathways have emerged throughout the discovery of specialized pro-resolving lipid mediator (SPM; resolvins, maresins, and protectins) dysregulation across the ILD spectra, positioning these endogenous molecules as promising therapeutic candidates for modulating maladaptive inflammation and promoting tissue repair. Over the past decade, this paradigm has catalyzed extensive translational research into SPM-based interventions as precision therapeutics for respiratory inflammation. In asthma, they reduce mucus hypersecretion, bronchial hyperreactivity, and airway inflammation, with prenatal SPM exposure potentially lowering offspring disease risk. In COPD, SPMs attenuate amyloid A-driven inflammation, normalizing cytokine/chemokine imbalances and oxidative stress and mitigating COVID-19-associated cytokine storm, enhancing survival. This review synthesizes SPMs' pharmacotherapeutic mechanisms in ILDs and evaluates current preclinical and clinical evidence.
650    _2
$a lidé $7 D006801
650    _2
$a zvířata $7 D000818
650    _2
$a COVID-19 $x metabolismus $7 D000086382
650    12
$a plicní nemoci $x farmakoterapie $x metabolismus $7 D008171
650    _2
$a kyseliny dokosahexaenové $x terapeutické užití $x metabolismus $7 D004281
650    _2
$a SARS-CoV-2 $7 D000086402
650    _2
$a chronická obstrukční plicní nemoc $x farmakoterapie $x metabolismus $7 D029424
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Duran, Pablo $u Endocrine and Metabolic Diseases Research Center, School of Medicine, University of Zulia, Maracaibo 4001, Venezuela $1 https://orcid.org/0000000280301780
700    1_
$a Garrido, Bermary $u Endocrine and Metabolic Diseases Research Center, School of Medicine, University of Zulia, Maracaibo 4001, Venezuela $1 https://orcid.org/0000000255227697
700    1_
$a Manzano, Alexander $u Endocrine and Metabolic Diseases Research Center, School of Medicine, University of Zulia, Maracaibo 4001, Venezuela $1 https://orcid.org/0000000166528834
700    1_
$a Navarro, Carolina $u Endocrine and Metabolic Diseases Research Center, School of Medicine, University of Zulia, Maracaibo 4001, Venezuela
700    1_
$a Silva, Aljadis $u Endocrine and Metabolic Diseases Research Center, School of Medicine, University of Zulia, Maracaibo 4001, Venezuela $1 https://orcid.org/0000000255010383
700    1_
$a Rojas, Milagros $u Endocrine and Metabolic Diseases Research Center, School of Medicine, University of Zulia, Maracaibo 4001, Venezuela $1 https://orcid.org/0000000327648846
700    1_
$a De Sanctis, Juan Bautista $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, 77900 Olomouc, Czech Republic $1 https://orcid.org/0000000254804608
700    1_
$a Radzioch, Danuta $u The Research Institute of the McGill, University Health Center, McGill University, Montreal, QC H0H H9Z, Canada
700    1_
$a Rivera-Porras, Diego $u Universidad de la Costa, Departamento de Productividad e Innovación, Barranquilla 080001, Atlántico, Colombia $1 https://orcid.org/0000000321693208
700    1_
$a Paredes, Carlos Silva $u Universidad del Zulia, Facultad de Medicina, Departamento de Ciencias Fisiológicas, Maracaibo 4001, Venezuela $1 https://orcid.org/0000000284830276
700    1_
$a Bermúdez, Valmore $u Universidad Simón Bolívar, Facultad de Ciencias de la Salud, Centro de Investigaciones en Ciencias de la Vida, Barranquilla 080001, Atlántico, Colombia $1 https://orcid.org/0000000318808887
773    0_
$w MED00180394 $t Molecules $x 1420-3049 $g Roč. 30, č. 10 (2025)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40430385 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250708 $b ABA008
991    __
$a 20250731091155 $b ABA008
999    __
$a ok $b bmc $g 2366514 $s 1252837
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 30 $c 10 $e 20250519 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
LZP    __
$a Pubmed-20250708

Najít záznam

Citační ukazatele

Možnosti archivace